CD56-positive acute lymphoblastic leukemia

Acta Haematologica

Volumn 114, Issue 3, 2005, Pages 160-163

  Matano, Sadaya ^a   Terahata, Shintaro ^a   Nakamura, Shigeo ^b   Kobayashi, Kazumi ^c   Sugimoto, Tatshuho ^a  

^a TONAMI GENERAL HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukemia; CD56 Natural killer cells; L Asparaginase

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; GEMTUZUMAB OZOGAMICIN; IMMUNOGLOBULIN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR BETA CHAIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; EPSTEIN BARR VIRUS; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA REMISSION; LUNG ABSCESS; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; TIME SERIES ANALYSIS;

AGED; ANTIGENS, CD56; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE;

EID: 27544505622     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087891     Document Type: Article

References (16)

1. Hercend T, Griffin JD, Bensussan A, Schmidt RE, Edson MA, Brennan A, Murray C, Daley JF, Schlossman SF, Ritz J: Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 1985;75:932-943.
2. Paietta E, Neuberg D, Richards S, Bennett JM, Han L, Racevskis J, Dewald G, Rowe JM, Wiernik PH; Eastern Cooperative Oncology Group: Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. Am J Hematol 2001;66:189-196.
3. Mann KP, DeCastro CM, Liu J, Moore JO, Bigner SH, Traweek ST: Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Am J Clin Pathol 1997;107:653-660.
4. Hammer RD, Vnencak-Jones CL, Manning SS, Glick AD, Kinney MC: Microvillous lymphomas are B-cell neoplasms that frequently express CD56. Mod Pathol 1998;11:239-246.
5. Suzuki R, Nakamura S: Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res 1999;23:615-624.
6. Chan JKC, Wong KF, Jaffe ES, Ralfkiaer E: Aggressive NK-cell leukemia; in Jaffe ES, Harris N, Stein HJ, Vardiman J (eds): World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoiectic and Lymphoid Tissues. Lyon, IARC Press, 2001, pp 198-200.
7. Chan JKC, Jaffe ES, Ralfkiaer E: Extranodal NK/T-cell lymphoma; in Jaffe ES, Harris N, Stein HJ, Vardiman J (eds): World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoiectic and Lymphoid Tissues. Lyon, IARC Press, 2001, pp 204-207.
8. Chan JKC, Jaffe ES, Ralfkiaer E: Blastic NK-cell lymphoma; in Jaffe ES, Harris N, Stein HJ, Vardiman J (eds): World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoiectic and Lymphoid Tissues. Lyon, IARC Press, 2001, pp 214-215.
9. + malignancies. Blood 2002;99:1556-1563.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991;78:325-329.
11. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S: CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood 1997;90:2417-2428.
12. Inaba T, Shimazaki C, Sumikuma T, Ochiai N, Okano A, Hatsuse M, Ashihara E, Kobayashi Y, Rin K, Murakami S, Haruyama H, Fujita N, Nakagawa M: Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia. Leuk Res 2001;25:109-113.
13. Suzuki R, Murata M, Kami M, Ohtake S, Asou N, Kodera Y, Tomonaga M, Masaki Y, Kusumoto S, Takeuchi J, Matsuda S, Hirai H, Yorimitsu S, Hamajima N, Seto M, Shimoyama M, Ohno R, Morishima Y, Nakamura S: Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0. Int J Hematol 2003;77:482-489.
14. Matano S, Nakamura S, Nakamura S, Annen Y, Hattori N, Kobayashi K, Kyoda K, Sugimoto T: Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association. Acta Haematol 1999;101:206-208.
15. Bayerl MG, Rakozy CK, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M: Elastic natural killer cell lymphoma/leukemia: a report of seven cases. Am J Clin Pathol 2002;117:41-50.
16. Mukai HY, Kojima H, Suzukawa K, Hori M, Komeno T, Hasegawa Y, Ninomiya H, Mori N, Nagasawa T: High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma. Leuk Lymphoma 1999;32:583-588.